Advisor Group’s Veracyte VCYT Stock Holding History

Advisor Group’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$36K	Buy	1,279 +327	+34%	+$8.46K	﹤0.01%	3639
2019 Q3	$23K	Sell	952 -41	-4%	-$1.09K	﹤0.01%	3875
2019 Q2	$29K	Buy	+993	New	+$24.8K	﹤0.01%	3732
2018 Q1	–	Sell	-650	Closed	-$4K	–	5072
2017 Q4	$4K	Hold	650	–	–	﹤0.01%	4517
2017 Q3	$6K	Hold	650	–	–	﹤0.01%	4216
2017 Q2	$5K	Hold	650	–	–	﹤0.01%	4255
2017 Q1	$6K	Hold	650	–	–	﹤0.01%	4048
2016 Q4	$5K	Buy	+650	New	+$4.86K	﹤0.01%	3952

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Advisor Group's VCYT Position: Q4 2019 in Review

Advisor Group increased its Veracyte (VCYT) stake by 34% in Q4 2019, buying an estimated $8.46K and bringing the position to 1,279 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #3639.

Advisor Group first reported a position in VCYT in Q4 2016 and has held it in 8 quarters since. 179 funds tracked by Wall St. Rank hold VCYT as of Q4 2019.

Advisor Group held 1,279 shares of Veracyte worth $36K as of Q4 2019.
Advisor Group bought 327 Veracyte shares in Q4 2019, an estimated $8.46K.
Veracyte made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3639 holding.
Advisor Group first reported a position in Veracyte in Q4 2016 and has held it in 8 quarters since.
179 funds tracked by Wall St. Rank held Veracyte as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.